Condition
Symptomatic Intracranial Atherosclerotic Stenosis
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (2)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07542938Not ApplicableNot Yet RecruitingPrimary
Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis
NCT07197970Phase 3RecruitingPrimary
Drug- Eluting Stent for Symptomatic Intracranial Arterial Stenosis
NCT07119918Phase 3Not Yet RecruitingPrimary
PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis
Showing all 3 trials